Tradestie Institutional Equity Comparison Engine

ADVB vs LABT โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ADVB Overall Edge

ADVB Captures Institutional Edge (2โ€“0 Pillars ยท 7โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Advanced Biomed Inc. Common Stock (ADVB) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, ADVB trades at N/M Forward P/E with -4883.8% operating margin (+0.0% YoY revenue) versus LABT at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, ADVB sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against LABT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ADVB N/M vs LABT N/M Fwd P/E
Growth & Margin Winner ADVB
Op Margin -4883.8% vs N/A ยท YoY +0.0% vs N/A
Momentum & Technical Winner ADVB
1Y +299.2% vs -97.2% ยท 52W Pos 6% vs 1%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
ADVB NASDAQ
Advanced Biomed Inc. Common Stock
Services-Medical Laboratories
$1.65
-5.71% 1D
Market Cap $2.9M
1M Return -52.31%
1Y Return +299.23%
Forward P/E N/M
Unified AI Score
43.5 / 100 HOLD
Tech 33.0 Fund 48.0 Flow 50.0 Mom 60.0
LABT US Equity
LABT
Institutional Equity
$0.24
+15.03% 1D
Market Cap N/A
1M Return -49.97%
1Y Return -97.17%
Forward P/E N/M
Unified AI Score
47.5 / 100 HOLD
Tech 45.0 Fund 48.0 Flow 50.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ADVB +299.23% LABT -97.17% Spread: +22.67 pp (ADVB Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ADVB TTM Op. Margin: -4883.8% LABT TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ADVB vs LABT. Trailing 12-month operating profitability (ADVB -4883.8% vs LABT N/A) and valuation multiples (ADVB N/M vs LABT N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ADVB (7) vs LABT (1)
Institutional Metric ADVB LABT Criterion Row Winner
Market Capitalization Scale $2.9M N/A Larger Scale ADVB
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% N/A Higher Growth ADVB
Operating Margin (TTM) Profitability -4883.8% N/A Higher Margin ADVB
Net Profit Margin Profitability 5231.3% N/A Higher Margin ADVB
Return on Equity (ROE) Capital Efficiency -79.5% N/A Higher ROE ADVB
52-Week Range Position Momentum 6% ($0โ€“$24) 1% ($0โ€“$10) Stronger Trend ADVB
Beta / 30D Volatility Risk Regime 0.26ฮฒ ยท 216% Vol -8.45ฮฒ ยท 672% Vol Lower Realized Risk ADVB
Unified Institutional Score Composite Signal 43.5 / 100 (HOLD) 47.5 / 100 (HOLD) Higher Composite LABT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ADVB vs LABT Buy Guide
ADVB UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ADVB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
LABT UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live LABT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ADVB nor LABT registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.